T1	Participants 111 144	treatment of Helicobacter pylori.
T2	Participants 213 242	Helicobacter pylori infection
T3	Participants 483 516	patients with H. pylori infection
T4	Participants 518 634	Sixty patients with peptic ulcer (gastric, 32 patients; duodenal, 28 patients) who had a history of ulcer recurrence
T5	Participants 925 968	Forty-eight patients completed the protocol
